Novius Company

We will talk a Lightning Talk at KLSAP2023

About The Kansai Life Science Accelerator Program (KLSAP) was launched in 2020 to provide Japanese startups with an online acceleration program by the U.S. accelerator California Life Sciences (CLS) to support their overseas business development. The KLSAP was launched in 2020 to provide an online acceleration program for Japanese startups by the U.S. accelerator California

We will talk a Lightning Talk at KLSAP2023 Read More »

Incorporated “NOVIUS Company,” a local subsidiary in Delaware, U.S.A.

(Head office: Hachioji City, Tokyo; Representative Director: Tomoko Fujino), which is engaged in the further spread of real-time 2D to 3D technology that creates stereoscopic images using AI to generate medical-related images using artificial intelligence technology in the field of digital health, as well as joint research and development with the National Cancer Center Hospital,

Incorporated “NOVIUS Company,” a local subsidiary in Delaware, U.S.A. Read More »

We’re able to obtain an NCAGE CODE number.

We are pleased to announce that we have obtained the NCAGE code “JB211” as of April 18, 2023. The NGAGE code is a five-digit code (a combination of letters and numbers) used in transactions with NATO countries, the U.S. federal government, and U.S. military agencies. The acquisition of this code will enable us to conduct

We’re able to obtain an NCAGE CODE number. Read More »

We started AGI (Artificial General Intelligence) development this year

We are pleased to announce that we will begin developing/providing AGI (Artificial General Intelligence) this year. The development has already started and will be provided on a contract basis from the end of this month, April. In the past, we have developed what is called specialized AI (AI that can detect something or respond only

We started AGI (Artificial General Intelligence) development this year Read More »

we Selected as one of the 10 finalists for the 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC

The 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC we Selected as one of the 10 finalists About The 31st General Assembly of the Japanese Association of Medical Sciences Exposition The theme of the 31st Annual Meeting, to be held in 2023, is “Big Data Opens the Way to the

we Selected as one of the 10 finalists for the 31st General Assembly of the Japanese Association of Medical Sciences Exposition x CIC Read More »

AI Generated Advanced Research & Development NCC (National Cancer Center) Concluded Joint Research, And Development Agreement With NOVIUS ( Media Articles Published In Japan

―ObjectThe objective of this project is to improve the accuracy of diagnosis by using AI technology to convert 2D fluoroscopic images of the lesion into 3D in real-time, enabling the recognition of the \”front\” or \”back\” of the image and facilitating the guidance of the bronchoscope to the lesion. ―EffectThe bronchoscope radial can efficiently reach

AI Generated Advanced Research & Development NCC (National Cancer Center) Concluded Joint Research, And Development Agreement With NOVIUS ( Media Articles Published In Japan Read More »